Lind Global Fund III LP - Sep 12, 2025 SCHEDULE 13G Report for Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

Filing Manager
Lind Global Fund III LP
Reporting Manager
Lind Global Fund III LP
Security
Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share
Symbol
SLXN
Shares outstanding
2.26M shares
Disclosed Ownership
224K shares
Ownership
9.9%
Form type
SCHEDULE 13G
Date filed
9/18/2025, 05:47 PM
Date of event
Sep 12, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lind Global Fund III LP 9.9% 224K 224K 0 By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
Lind Global Partners III LLC 9.9% 224K 224K 0 By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
EASTON JEFF 9.9% 224K 224K 0 /s/ Jeff Easton Jeff Easton